pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3973 |
Genomic Coordinates | chr11: 36010098 - 36010204 |
Description | Homo sapiens miR-3973 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3973 | ||||||||||||||||||
Sequence | 84| ACAAAGUACAGCAUUAGCCUUAG |106 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CBX3 | ||||||||||||||||||||
Synonyms | HECH, HP1-GAMMA, HP1Hs-gamma | ||||||||||||||||||||
Description | chromobox 3 | ||||||||||||||||||||
Transcript | NM_007276 | ||||||||||||||||||||
Other Transcripts | NM_016587 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CBX3 | |||||||||||||||||||||
3'UTR of CBX3 (miRNA target sites are highlighted) |
>CBX3|NM_007276|3'UTR 1 TTGTTCACATTGTTCTTTTATATATATTTATATATATATATAAAAATTGGGTCTTAGATTTTGATTTACTAGTGTGACAA 81 AATAACTACATCCTAATGAAAATCAAGTTTGATATGTTTGTTTTGAAAGTAGCGTTGGAAGAGTTGTTGGGGGTTTTTTG 161 CATCCATAGCACTGGTTACTTTGAACAAATAAATAAAAGCTTTCTGTAGTTGCTTCCTTTATCAGAAAAGAACATTTGAT 241 ACCATGGTATATCATTTCCTCTTCATTAAAGAACAGCTTTTCTAAATGTTGGGGGAAATGTCCATAGTCATTACTCAGTC 321 AAAACTTGTGTTCTCATGAGCCTAAGGACCATTCTAGATTTATTACGTGTTTTTTGTGTGTGTGTGTGTGTGTGTGTGTG 401 TGTGTATCCATAAAATGCATATGTAAATTTTTTTTTGTTTTTAAGCATTCACCCAAACAAAAAAATCACAGGTAAACCCA 481 TGTTTCTGAGATGCCATTATTCCAAGCAAAATAAGAGATAATCCCTTCAAGTTAAATTGAAAATTTTCCTGAAACCATAC 561 ATTTCAAGTGAAATAAGTAATTCTAGATAGGACAATTTAAATTGGATAATTTTAAAGTGTCTATAATTGCAGTGGTTTAT 641 TTGCAAAATTCCTAAAAGGAAAAATTTTATCACTGCCATCACAGCAGGTTTCCTCATCCAGATGAGGAAACTAGACAAAT 721 GCTAGTGTGTTTTAACTAGCTAAACAAAACTAAGTTAAATGAACATTTAAAAGTTTCCCTAGCGGGCCATTCCTTAGCAA 801 AATGTTGGAATCCCTGTTGCTACATTGACTAAAAGGTCATGATGAATGGAATATGTAAGACTTGGCTCATAGAAACCTAA 881 TCAGATGGTTAGAGGTGTTGGCAGTTTAGGACCTGCTGTCATAAATGTGTGAACAACCTTTTGTAACCTAACCTATTGAC 961 CTGCATGTTTTTTCTTTACCCCAATTCATTACATGGAGGCTCAATCTTGAGTTTGCTTTACTGGTTCAGCAAAAGCCAGG 1041 AAGAACAACTTTGTAGTAATCAAAATGTTATCCAACTGTATATTGTTTACTTTATTGTAAATACTGGTGAACAGTGGTTA 1121 ATAAATAGTTTTATATTCCTTTATGCAATTATTAGACTTTTTTCTTTATTTGATATGCCTTTACAGTAGAAATAGAAATG 1201 CCCACACTCATTGGATTATCTTTGTTTATAAGTTAGATGATACCAGTAAGGCATTACAGTACATATCCTAGATCTTTTGA 1281 GCTTACGAGTTTTAAACTTGAATATGTATTTCCACAGGAATGTTTCCACAGTTGGGAAATAAAAGTTTCATGTGATGCCT 1361 AGGGTCAATTGTCTCATTAAAATGAGGTTTTAAATTCTG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760632. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000337620.4 | 3UTR | CAUCCAUAGCACUGGUUACUUUGAACAAAUAAAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000337620.4 | 3UTR | UUUUUUGCAUCCAUAGCACUGGUUACUUUGAACAAAUAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000337620.4 | 3UTR | CAUCCAUAGCACUGGUUACUUUGAACAAAUAAAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
136 hsa-miR-3973 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060560 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT060977 | LAMC1 | laminin subunit gamma 1 | 2 | 2 | ||||||||
MIRT067617 | TMPO | thymopoietin | 2 | 2 | ||||||||
MIRT072503 | RAB8B | RAB8B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT092048 | ABHD5 | abhydrolase domain containing 5 | 2 | 6 | ||||||||
MIRT093449 | MSMO1 | methylsterol monooxygenase 1 | 2 | 2 | ||||||||
MIRT093538 | GALNT7 | polypeptide N-acetylgalactosaminyltransferase 7 | 2 | 6 | ||||||||
MIRT095404 | UBE2D2 | ubiquitin conjugating enzyme E2 D2 | 2 | 2 | ||||||||
MIRT103367 | CBX3 | chromobox 3 | 2 | 2 | ||||||||
MIRT110447 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 10 | ||||||||
MIRT161196 | ZBTB38 | zinc finger and BTB domain containing 38 | 2 | 2 | ||||||||
MIRT161903 | FXR1 | FMR1 autosomal homolog 1 | 2 | 2 | ||||||||
MIRT192775 | B2M | beta-2-microglobulin | 2 | 2 | ||||||||
MIRT195782 | ATMIN | ATM interactor | 2 | 6 | ||||||||
MIRT228194 | BNC2 | basonuclin 2 | 2 | 2 | ||||||||
MIRT237882 | WHSC1 | nuclear receptor binding SET domain protein 2 | 2 | 4 | ||||||||
MIRT249021 | PABPC3 | poly(A) binding protein cytoplasmic 3 | 2 | 8 | ||||||||
MIRT273958 | SPRYD4 | SPRY domain containing 4 | 2 | 2 | ||||||||
MIRT309023 | USP53 | ubiquitin specific peptidase 53 | 2 | 2 | ||||||||
MIRT312596 | G3BP1 | G3BP stress granule assembly factor 1 | 2 | 4 | ||||||||
MIRT315536 | MARCKS | myristoylated alanine rich protein kinase C substrate | 2 | 2 | ||||||||
MIRT319305 | CAV1 | caveolin 1 | 2 | 2 | ||||||||
MIRT324436 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT325710 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT340681 | THRAP3 | thyroid hormone receptor associated protein 3 | 2 | 2 | ||||||||
MIRT404628 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT443473 | ACPP | acid phosphatase, prostate | 2 | 2 | ||||||||
MIRT443545 | ZNRF2 | zinc and ring finger 2 | 2 | 2 | ||||||||
MIRT446290 | RIMKLB | ribosomal modification protein rimK like family member B | 2 | 2 | ||||||||
MIRT447066 | MCC | mutated in colorectal cancers | 2 | 2 | ||||||||
MIRT447365 | RASA2 | RAS p21 protein activator 2 | 2 | 2 | ||||||||
MIRT450079 | ZNF354C | zinc finger protein 354C | 2 | 2 | ||||||||
MIRT454270 | PSMA1 | proteasome subunit alpha 1 | 2 | 2 | ||||||||
MIRT456032 | CRYZ | crystallin zeta | 2 | 8 | ||||||||
MIRT462069 | CCDC77 | coiled-coil domain containing 77 | 2 | 4 | ||||||||
MIRT466379 | TGOLN2 | trans-golgi network protein 2 | 2 | 4 | ||||||||
MIRT470352 | PPP2R5E | protein phosphatase 2 regulatory subunit B'epsilon | 2 | 2 | ||||||||
MIRT471866 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 4 | ||||||||
MIRT474453 | KLHL11 | kelch like family member 11 | 2 | 8 | ||||||||
MIRT476188 | GOLGA8A | golgin A8 family member A | 2 | 10 | ||||||||
MIRT476645 | G2E3 | G2/M-phase specific E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT481544 | ARL10 | ADP ribosylation factor like GTPase 10 | 2 | 10 | ||||||||
MIRT481791 | APEX1 | apurinic/apyrimidinic endodeoxyribonuclease 1 | 2 | 2 | ||||||||
MIRT482527 | ACTB | actin beta | 2 | 4 | ||||||||
MIRT485570 | FOXQ1 | forkhead box Q1 | 2 | 2 | ||||||||
MIRT486011 | LPAR2 | lysophosphatidic acid receptor 2 | 2 | 2 | ||||||||
MIRT495182 | MUC20 | mucin 20, cell surface associated | 2 | 2 | ||||||||
MIRT496047 | MORC1 | MORC family CW-type zinc finger 1 | 2 | 2 | ||||||||
MIRT497114 | JRKL | JRK like | 2 | 2 | ||||||||
MIRT497494 | RGS17 | regulator of G protein signaling 17 | 2 | 2 | ||||||||
MIRT497752 | OXGR1 | oxoglutarate receptor 1 | 2 | 2 | ||||||||
MIRT500217 | INHBA | inhibin beta A subunit | 2 | 10 | ||||||||
MIRT501079 | SMAD7 | SMAD family member 7 | 2 | 8 | ||||||||
MIRT501453 | PTPN4 | protein tyrosine phosphatase, non-receptor type 4 | 2 | 8 | ||||||||
MIRT502793 | CELSR3 | cadherin EGF LAG seven-pass G-type receptor 3 | 2 | 6 | ||||||||
MIRT502879 | CDK4 | cyclin dependent kinase 4 | 2 | 8 | ||||||||
MIRT505796 | RSBN1 | round spermatid basic protein 1 | 2 | 8 | ||||||||
MIRT506345 | NUP54 | nucleoporin 54 | 2 | 6 | ||||||||
MIRT507415 | ELK4 | ELK4, ETS transcription factor | 2 | 4 | ||||||||
MIRT509272 | NPM3 | nucleophosmin/nucleoplasmin 3 | 2 | 6 | ||||||||
MIRT514931 | TRIM73 | tripartite motif containing 73 | 2 | 2 | ||||||||
MIRT515441 | TRIM74 | tripartite motif containing 74 | 2 | 2 | ||||||||
MIRT516026 | A1CF | APOBEC1 complementation factor | 2 | 2 | ||||||||
MIRT517375 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT527925 | FRY | FRY microtubule binding protein | 2 | 2 | ||||||||
MIRT529611 | H1F0 | H1 histone family member 0 | 2 | 2 | ||||||||
MIRT530606 | C7orf33 | chromosome 7 open reading frame 33 | 2 | 4 | ||||||||
MIRT530970 | EXO5 | exonuclease 5 | 2 | 4 | ||||||||
MIRT532108 | RRP8 | ribosomal RNA processing 8 | 2 | 2 | ||||||||
MIRT533006 | ZFHX3 | zinc finger homeobox 3 | 2 | 4 | ||||||||
MIRT533103 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT533231 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT534073 | SRPK1 | SRSF protein kinase 1 | 2 | 2 | ||||||||
MIRT534457 | SCML2 | Scm polycomb group protein like 2 | 2 | 4 | ||||||||
MIRT536678 | IKZF5 | IKAROS family zinc finger 5 | 2 | 2 | ||||||||
MIRT538224 | CYR61 | cysteine rich angiogenic inducer 61 | 2 | 2 | ||||||||
MIRT539218 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 4 | ||||||||
MIRT541157 | PABPC1 | poly(A) binding protein cytoplasmic 1 | 2 | 4 | ||||||||
MIRT552682 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT554457 | SAMD8 | sterile alpha motif domain containing 8 | 2 | 2 | ||||||||
MIRT556688 | KLHL28 | kelch like family member 28 | 2 | 2 | ||||||||
MIRT558162 | ELAVL2 | ELAV like RNA binding protein 2 | 2 | 2 | ||||||||
MIRT558195 | EIF2S1 | eukaryotic translation initiation factor 2 subunit alpha | 2 | 4 | ||||||||
MIRT558752 | CHERP | calcium homeostasis endoplasmic reticulum protein | 2 | 2 | ||||||||
MIRT561871 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 2 | ||||||||
MIRT567443 | GNG12 | G protein subunit gamma 12 | 2 | 2 | ||||||||
MIRT568399 | ATF7IP | activating transcription factor 7 interacting protein | 2 | 2 | ||||||||
MIRT569178 | DMD | dystrophin | 2 | 2 | ||||||||
MIRT571465 | CCDC80 | coiled-coil domain containing 80 | 2 | 2 | ||||||||
MIRT575987 | Fem1a | feminization 1 homolog a (C. elegans) | 2 | 5 | ||||||||
MIRT606844 | FEM1A | fem-1 homolog A | 2 | 7 | ||||||||
MIRT615813 | COQ7 | coenzyme Q7, hydroxylase | 2 | 2 | ||||||||
MIRT619491 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 2 | ||||||||
MIRT624354 | CHRM3 | cholinergic receptor muscarinic 3 | 2 | 2 | ||||||||
MIRT625979 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | 2 | 2 | ||||||||
MIRT628564 | MELK | maternal embryonic leucine zipper kinase | 2 | 2 | ||||||||
MIRT631329 | CARHSP1 | calcium regulated heat stable protein 1 | 2 | 2 | ||||||||
MIRT639435 | PKP1 | plakophilin 1 | 2 | 2 | ||||||||
MIRT640366 | C1orf210 | chromosome 1 open reading frame 210 | 2 | 2 | ||||||||
MIRT640701 | SKI | SKI proto-oncogene | 2 | 2 | ||||||||
MIRT640718 | CEP68 | centrosomal protein 68 | 2 | 2 | ||||||||
MIRT641217 | TRIB1 | tribbles pseudokinase 1 | 2 | 4 | ||||||||
MIRT642271 | SMIM17 | small integral membrane protein 17 | 2 | 2 | ||||||||
MIRT644011 | PPP1R3G | protein phosphatase 1 regulatory subunit 3G | 2 | 2 | ||||||||
MIRT645146 | CUBN | cubilin | 2 | 2 | ||||||||
MIRT653158 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | 2 | 2 | ||||||||
MIRT654475 | RANBP2 | RAN binding protein 2 | 2 | 2 | ||||||||
MIRT656177 | MRPL44 | mitochondrial ribosomal protein L44 | 2 | 2 | ||||||||
MIRT658719 | ELMOD2 | ELMO domain containing 2 | 2 | 2 | ||||||||
MIRT658857 | DTX3L | deltex E3 ubiquitin ligase 3L | 2 | 2 | ||||||||
MIRT663935 | ZNF554 | zinc finger protein 554 | 2 | 2 | ||||||||
MIRT664901 | EMC7 | ER membrane protein complex subunit 7 | 2 | 2 | ||||||||
MIRT668801 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT673514 | TNFAIP8L1 | TNF alpha induced protein 8 like 1 | 2 | 4 | ||||||||
MIRT683192 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | 2 | 2 | ||||||||
MIRT684049 | FOLR1 | folate receptor 1 | 2 | 2 | ||||||||
MIRT685543 | PI4K2B | phosphatidylinositol 4-kinase type 2 beta | 2 | 2 | ||||||||
MIRT690365 | RPL37A | ribosomal protein L37a | 2 | 2 | ||||||||
MIRT691612 | IPP | intracisternal A particle-promoted polypeptide | 2 | 2 | ||||||||
MIRT691651 | SLC43A3 | solute carrier family 43 member 3 | 2 | 2 | ||||||||
MIRT694108 | ZNF446 | zinc finger protein 446 | 2 | 2 | ||||||||
MIRT695618 | VBP1 | VHL binding protein 1 | 2 | 2 | ||||||||
MIRT695925 | ZNF174 | zinc finger protein 174 | 2 | 2 | ||||||||
MIRT696445 | SUGP1 | SURP and G-patch domain containing 1 | 2 | 2 | ||||||||
MIRT697983 | TSPAN6 | tetraspanin 6 | 2 | 2 | ||||||||
MIRT699769 | SEMA4D | semaphorin 4D | 2 | 2 | ||||||||
MIRT702946 | HIPK3 | homeodomain interacting protein kinase 3 | 2 | 2 | ||||||||
MIRT703385 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 2 | ||||||||
MIRT704011 | EFCAB14 | EF-hand calcium binding domain 14 | 2 | 2 | ||||||||
MIRT704182 | DNAJB4 | DnaJ heat shock protein family (Hsp40) member B4 | 2 | 2 | ||||||||
MIRT704446 | CTNNB1 | catenin beta 1 | 2 | 2 | ||||||||
MIRT708514 | CHCHD3 | coiled-coil-helix-coiled-coil-helix domain containing 3 | 2 | 2 | ||||||||
MIRT713068 | ENTHD1 | ENTH domain containing 1 | 2 | 2 | ||||||||
MIRT715799 | TBL3 | transducin beta like 3 | 2 | 2 | ||||||||
MIRT716441 | RPS24 | ribosomal protein S24 | 2 | 2 | ||||||||
MIRT719421 | B4GALNT3 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|